Tina Moore

You are tuned into The Dr. Tina Show with Dr. Tina Moore. For more, visit drtina.com. On this episode of The Dr. Tina Show, I am excited for this one. I got to sit down and have a great conversation with my buddy, Dave Knapp. Dave and I met through the online space when I was deplatformed back in September for, I believe, talking about microdosing GLP-1s.

He has built an entire platform called On The Pen. And his life's mission, he's become an independent journalist of sorts. That's not what his background was in. But he has made it his life's mission to connect people who are utilizing GLP-1 agonists. He is a man living with a disease of obesity, the disease of type 2 diabetes. And he knows this world well.

He has built an entire platform called On The Pen. And his life's mission, he's become an independent journalist of sorts. That's not what his background was in. But he has made it his life's mission to connect people who are utilizing GLP-1 agonists. He is a man living with a disease of obesity, the disease of type 2 diabetes. And he knows this world well.

He has built an entire platform called On The Pen. And his life's mission, he's become an independent journalist of sorts. That's not what his background was in. But he has made it his life's mission to connect people who are utilizing GLP-1 agonists. He is a man living with a disease of obesity, the disease of type 2 diabetes. And he knows this world well.

And he's built this wonderful, expansive community of like-minded people who are all utilizing these peptides with life-changing impacts. He keeps us abreast on what's happening in the news.

And he's built this wonderful, expansive community of like-minded people who are all utilizing these peptides with life-changing impacts. He keeps us abreast on what's happening in the news.

And he's built this wonderful, expansive community of like-minded people who are all utilizing these peptides with life-changing impacts. He keeps us abreast on what's happening in the news.

And so I brought him on today because, A, I wanted you guys to get an update on what's happening with the FDA versus the compounding pharmacies and those ongoing trials and what's happening there because the future of compounded GLP-1s may be in jeopardy. So I want you to get the inside scoop on that. He explains it so well.

And so I brought him on today because, A, I wanted you guys to get an update on what's happening with the FDA versus the compounding pharmacies and those ongoing trials and what's happening there because the future of compounded GLP-1s may be in jeopardy. So I want you to get the inside scoop on that. He explains it so well.

And so I brought him on today because, A, I wanted you guys to get an update on what's happening with the FDA versus the compounding pharmacies and those ongoing trials and what's happening there because the future of compounded GLP-1s may be in jeopardy. So I want you to get the inside scoop on that. He explains it so well.

Whether you're on GLP-1s or care about them or not, this is a conversation you need to hear. Number two, we talk about the PBMs, which are the middlemen who are gouging us all and driving up prices of medications and pharmaceuticals. So that's something you guys need to know about as well. We talk about what it's like to live with a disease of obesity and what that means and how he's gone keto.

Whether you're on GLP-1s or care about them or not, this is a conversation you need to hear. Number two, we talk about the PBMs, which are the middlemen who are gouging us all and driving up prices of medications and pharmaceuticals. So that's something you guys need to know about as well. We talk about what it's like to live with a disease of obesity and what that means and how he's gone keto.

Whether you're on GLP-1s or care about them or not, this is a conversation you need to hear. Number two, we talk about the PBMs, which are the middlemen who are gouging us all and driving up prices of medications and pharmaceuticals. So that's something you guys need to know about as well. We talk about what it's like to live with a disease of obesity and what that means and how he's gone keto.

He's done the eat less, move more, how his community lives. the struggles that they have and how these peptides have been absolutely life-changing for them, for leveling the metabolic playing field, as he calls it. And lastly, we even touch on a few things that we both agree Maha may be missing the mark on. So without further ado, let's jump in. We get right into it. This is Dave Knapp.

He's done the eat less, move more, how his community lives. the struggles that they have and how these peptides have been absolutely life-changing for them, for leveling the metabolic playing field, as he calls it. And lastly, we even touch on a few things that we both agree Maha may be missing the mark on. So without further ado, let's jump in. We get right into it. This is Dave Knapp.

He's done the eat less, move more, how his community lives. the struggles that they have and how these peptides have been absolutely life-changing for them, for leveling the metabolic playing field, as he calls it. And lastly, we even touch on a few things that we both agree Maha may be missing the mark on. So without further ado, let's jump in. We get right into it. This is Dave Knapp.

Did you know that nearly 94% of US adults are metabolically compromised according to 2018 data published in 2021? Even more surprising, 80% of them have no idea. Shocking, right? That's why I've been beating the drum on metabolic health for decades in my clinical practice and on this podcast since day one.

Did you know that nearly 94% of US adults are metabolically compromised according to 2018 data published in 2021? Even more surprising, 80% of them have no idea. Shocking, right? That's why I've been beating the drum on metabolic health for decades in my clinical practice and on this podcast since day one.

Did you know that nearly 94% of US adults are metabolically compromised according to 2018 data published in 2021? Even more surprising, 80% of them have no idea. Shocking, right? That's why I've been beating the drum on metabolic health for decades in my clinical practice and on this podcast since day one.

A tool I found a long time ago that I absolutely love is the Continuous Glucose Monitor by NutriSense. NutriSense is here to challenge outdated beliefs about blood sugar and metabolic health. Because the more you know. NutriSense isn't just another health trend.